A new Canadian study finds COVID-19 protection from first doses varies widely between vaccine brands. In some cases, a single dose of AstraZeneca’s shot formed no antibodies at all. as Jamie Mauracher reports, The findings add urgency to Canada’s efforts to get second doses rolled out as fast as possible.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting